Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Clinical Trial to Compare Etrolizumab with Infliximab in Patients with Moderate to Severe Ulcerative Colitis Who Have not Received Treatment with Tumour Necrosis Factor Inhibitors (Gardenia)

    Phase III, randomized, multicenter double-blind, double dummy study to evaluate the efficacy and safety of Etrolizumab compared with Infliximab in patients with moderate to severe active Ulcerative Colitis who are naïve to TNF inhibitors

    • Autoimmune Disorder
    • Inflammatory Bowel Disease (IBD)
    • Ulcerative Colitis